Established on October 13, 2021, the joint venture is led by a team of doctoral graduates from the Hong Kong University of Science and Technology and established jointly with the National Innovation Center for High-Performance Medical Devices. The company is committed to providing patients with safe, effective and accurate diagnostic and treatment devices, starting with equipment for the early diagnosis of glaucoma, and to contribute to improving the vision of a wider population. The company cooperates with numerous research institutions and hospitals, including Hong Kong University of Science and Technology, Zhongshan Eye Center of Sun Yat-sen University and Shenzhen People's Hospital, to jointly promote the research and development of world-leading technologies and achieve breakthroughs in the production of domestically produced high-quality ophthalmic diagnostic and treatment devices and systems. Established on October 13, 2021, this joint venture is led by a postdoctoral team from the Hong Kong University of Science and Technology and jointly founded with the National Innovation Center for High-Performance Medical Devices. The company is committed to providing patients with safe, efficient, and precise diagnostic and treatment devices, starting with early glaucoma diagnostic equipment, and contributing to the visual health of a wider population. The company collaborates with numerous research institutions and hospitals, including the Hong Kong University of Science and Technology, Zhongshan Ophthalmic Center of Sun Yat-sen University, and Shenzhen People's Hospital, to jointly advance the research and development of world-leading technologies and achieve breakthroughs in domestically produced high-end ophthalmic diagnostic and treatment devices and systems.